COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03786419
Recruitment Status : Not yet recruiting
First Posted : December 26, 2018
Last Update Posted : December 26, 2018
ILS Clinical Research
Information provided by (Responsible Party):
Jorge Arturo Alatorre Alexander, Health Pharma Professional Research

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : June 2022